Mablink Bioscience
Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC).
Mablink Bioscience has raised €35M across 2 funding rounds from 9 investors, most recently a Series A round in Oct 2022. Based in Lyon, France; active in Healthtech. Data as of 28 Oct 2026.
Lyon, Francewww.mablink.com ↗
Total raised
€35M
€35,000,000
Funding rounds
2
Investors
9
distinct backers
Active since
2021-04
latest 2022-10
Funding by year
EUR raised per yearMablink Bioscience — funding by year — interactive chart.
Data table
| Mablink Bioscience — funding by year | |
|---|---|
| 2021 | €4.0M |
| 2022 | €31M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-17 | Series A | €31M | Crédit Agricole Création,Elaia Partners,Fondation Fournier-Majoie,Mérieux Equity Partners,Sham Innovation Santé,Simba Santé+2 more | View deal → |
| 2021-04-27 | Seed | €4.0M | Crédit Agricole Création,Elaia Partners,Fondation Fournier-Majoie,Pertinence Invest 2,Sham Innovation Santé,Simba Santé | View deal → |
Investors
9Related news
- Mablink Bioscience secures €31M to develop better treatment for cancer patientstechfundingnews.com · 2022-10
- finsmes.com
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData